Literature DB >> 18789068

Pulsed dye laser treatment for viral warts: a study of 120 patients.

Hyun Su Park1, Woo Seok Choi.   

Abstract

A prospective, non-blinded, non-randomized study on 120 wart patients treated with pulsed dye laser was performed to evaluate the efficacy and safety of pulsed dye laser treatment for viral warts and to demonstrate the proper application and effective technique of this method. The overall clearance rate was 49.5%. The clearance rates of flat warts, periungual warts, plantar warts and common warts were 67.6%, 51.1%, 47.6% and 44.3%, respectively. Overall, the response rates of pediatric warts, recalcitrant warts and old warts were superior to those of adult warts, simple warts and non-old warts, respectively; however, those trends were not statistically significant. We concluded that pulsed dye laser treatment is a safe, tolerable and relatively effective treatment method for viral warts. Pulsed dye laser treatment may be a more efficacious method for flat warts and recalcitrant periungual warts, and it can be an effective modality for newly-developed warts. The highest clearance rate was noted at a fluence of 9.5 J/cm2 (P < or = 0.05) and it is recommended that practitioners perform pulsed dye laser treatments for viral warts at the fluences of 9.0-9.5 J/cm2. A replacement of pulsed dye laser treatment should be considered unless prominent improvement is observed after three treatment sessions.

Entities:  

Mesh:

Year:  2008        PMID: 18789068     DOI: 10.1111/j.1346-8138.2008.00509.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  10 in total

Review 1.  Anogenital warts in pediatric population.

Authors:  Miguel Costa-Silva; Inês Fernandes; Acácio Gonçalves Rodrigues; Carmen Lisboa
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

2.  Recalcitrant molluscum contagiosum successfully treated with the pulsed dye laser.

Authors:  Tokuya Omi; Seiji Kawana
Journal:  Laser Ther       Date:  2013

3.  A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum.

Authors:  Srishti Jain; Yogesh S Marfatia
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

4.  Efficacy of pulsed dye laser treatment for common warts is not influenced by the causative HPV type: a prospective study.

Authors:  Yoseph Fichman; Assi Levi; Emmilia Hodak; Shlomit Halachmi; Sigal Mazor; Dana Wolf; Orit Caplan; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2017-12-07       Impact factor: 3.161

5.  Pulsed dye laser versus Nd:YAG laser in the treatment of plantar warts: a comparative study.

Authors:  Abd El-Shakor El-Mohamady; Ibrahim Mearag; Mohamed El-Khalawany; Ahmed Elshahed; Hisham Shokeir; Anas Mahmoud
Journal:  Lasers Med Sci       Date:  2013-11-12       Impact factor: 3.161

6.  Third degree formic acid chemical burn in the treatment of a hand wart: a case report and review of the literature.

Authors:  Nicolas Balagué; Philippe Vostrel; Jean-Yves Beaulieu; Jan van Aaken
Journal:  Springerplus       Date:  2014-08-05

7.  Cidofovir Intralesional Injection for Recalcitrant Common Warts: A Comparison with Sodium Tetradecyl Sulfate Intralesional Injection.

Authors:  Byung Ho Oh
Journal:  Ann Dermatol       Date:  2020-06-30       Impact factor: 1.444

8.  Treatment of plane warts with a low-dose oral isotretinoin.

Authors:  Hayder R Al-Hamamy; Husam Ali Salman; Nawar A Abdulsattar
Journal:  ISRN Dermatol       Date:  2012-12-12

9.  Topical immunotherapy with diphenylcyclopropenone is effective and preferred in the treatment of periungual warts.

Authors:  Yunseok Choi; Do Hun Kim; Sang Yun Jin; Ai-Young Lee; Seung Ho Lee
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

Review 10.  The effectiveness of lasers in the treatment of onychomycosis: a systematic review.

Authors:  Ivan R Bristow
Journal:  J Foot Ankle Res       Date:  2014-07-27       Impact factor: 2.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.